Skip to Main Content

Paper Details

A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
J Biol Chem
16
2017
Author NameAffiliation
Eugene T DillonUCD Conway Institute and.
Gerard CagneyUCD Conway Institute and.
  • 1 - 2

Datasets

Release 1.2